Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXICURE, INC.XCUR · Entity 8068 | Chief Medical Officer | November 15, 2021 | November 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXICURE, INC.
Report date November 15, 2021 · Filed November 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Reported balance
After 2021-11-15 transaction · row 1
1 source rowRow 1 · 2021-11-15 · Grant · Acquired 7,500 · Balance 15,000 F1: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Nov 23, 2021 16:45 UTC | EXICURE, INC. XCUR · Entity 8068 | GrantCommon Stock | 7,500 | $0.91 | $6,825.00 |
DisclosureSEC source: 0001209191-21-066474 · doc4.xml · nonDerivative · entry 1 Feltner Douglas E. · CIK 0001813344 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · kind: These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| May 14, 2021 Filed May 20, 2021 18:30 UTC | EXICURE, INC. XCUR · Entity 8068 | GrantCommon Stock | 7,500 | $1.27 | $9,525.00 |
DisclosureSEC source: 0001209191-21-034586 · doc4.xml · nonDerivative · entry 1 Feltner Douglas E. · CIK 0001813344 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 F1 · kind: These shares were acquired under the XCUR Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 17:42 UTC | EXICURE, INC. XCUR · Entity 8068 | GrantEmployee Stock Option (right to buy) · Derivative | 220,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-21-029059 · doc4.xml · derivative · entry 1 Feltner Douglas E. · CIK 0001813344 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2031-04-26 F1 · derivative.exercise_date: The shares subject to the option vest in 48 substantially equal monthly installments from the vesting commencement date of April 27, 2021, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 06:55 UTC | EXICURE, INC. XCUR · Entity 8068 | GrantEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001209191-20-034595 · doc4.xml · derivative · entry 1 Feltner Douglas E. · CIK 0001813344 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2030-06-02 F1 · derivative.exercise_date: This option vests 25% on May 18, 2021, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.